New Leaf Ventures Inc (OTCPK: NLVV.F)
Health Care · Pharmaceuticals · CA
$0.00
— today · 0.0% 1Y
New Leaf Ventures Inc (OTCPK: NLVV.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $30.00.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores New Leaf Ventures Inc across four factors: quality 8/100, value 51/100. Its strongest factor is value.
NLVV.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.00
- Revenue (TTM)
- $1.06M
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- -12.90
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 29.80M
- Employees
- —
- Next earnings
- —
About New Leaf Ventures Inc
New Leaf Ventures Inc. engages in processing, packaging, marketing, and distributing cannabis and related products. The company offers its products under the brand names of dama, Green State, Tasty Tokes, Astara, Goodies, and Dama Hemp. It also provides consulting, real property and equipment leasing, intellectual property licensing, and management services. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
- Founded
- 2018
- Listed since
- May 4, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.